Recent studies have shown the significant immunomodulatory functions of Megakaryocytes (MKs).
MK subpopulations reflect unique functional attributes showcasing varied functions and roles in health and diseases.
Megakaryocytes express various immune receptors, which enables them to detect pathogens and initiate immune responses, bridging innate and adaptive immunity.
MKs communicate with other immune cells by secreting cytokines that can influence the differentiation and development of B cells and plasma cells, directly shaping the immune response landscape.
Megakaryocytes exhibit dual roles as both defenders and facilitators of the inflammatory response. They produce interferons and enhance the expression of IFN-induced transmembrane protein 3 (IFITM3), thereby restricting viral entry and replication.
MKs have the potential to play a significant role in disease mechanisms like COVID-19.
MKs can limit the spread of pathogens, and the mechanistic pathways by which they sense and respond to bacterial threats continue to be an important area of research that links MKs with increasingly complex immune landscapes.
Research has identified a subset known as 'immune MKs' actively participate in immune responses, showing their roles in pathogen recognition.
Understanding the multifaceted roles of MKs can lead to uncharted paths in immunotherapy and targeted treatment approaches.
The emerging evidence positions megakaryocytes at the nexus of hemostasis and immunity, a realization that could reshape interventions in inflammatory, infectious, and autoimmune disorders.